Current Science

Bimal Prasanna Mohanty ¹, D. Karunakaran ¹, Arabinda Mahanty ¹, Satabdi Ganguly ¹, Dipesh Debnath ¹, Tandrima Mitra ¹, Sudeshna Banerjee ¹, Anil Prakash Sharma ¹, T. V. Sankar ², R. Anandan ², Suseela Mathew ², K. K. Asha ², Kajal Chakraborty ³, P. Vijayagopal ³, B. N. Paul ⁴, N. Sridhar ⁴, S. Chanda ⁴, Debajit Sarma ⁵, Nityanand Pandey ⁵, Neetu Shahi ⁵, Pushpita Das ⁵, Partha Das ⁵, Md. Shahbaz Akhtar ⁵, J. Syama Dayal ⁶, K. K. Vijayan ⁶, S. Kannappan ⁶, G. Venkateshwarlu ⁷, S. D. Singh ⁸, Madan Mohan ⁸, B. Meenakumari ⁸, S. Ayyappan ⁹

Affiliations
1 ICAR-Central Inland Fisheries Research Institute, Barrackpore, Kolkata 700 120, IN
2 ICAR-Central Institute of Fisheries Technology, Cochin 682 029, IN
3 ICAR-Central Marine Fisheries Research Institute, Cochin 682 018, IN
4 ICAR-Central Institute of Freshwater Aquaculture, Bhubhaneswar 751 002, IN
5 ICAR-Directorate of Coldwater Fisheries Research, Bhimtal 263 136, IN
6 ICAR-Central Institute of Brackishwater Aquaculture, Chennai 600 028, IN
7 ICAR-Central Institute of Fisheries Education, Mumbai 400 061, IN
8 ICAR-Fisheries Science Division, Krishi Anusandhan Bhawan II, Pusa, New Delhi 110 012, IN
9 Krishi Bhavan, Indian Council of Agricultural Research, New Delhi 110 012, IN

Abstract

No Abstract.

Full Text

   

Vikram Singh ¹, Kajal Chakraborty ², Lavina Vincent ²

Affiliations
1 Intellectual Property and Technology Management Unit, Indian Council of Agricultural Research, New Delhi 110 012, IN
2 Institute Technology Management Unit, Central Marine Fisheries Research Institute, Ernakulam North PO, P. B. No. 1603, Cochin 682 018, IN

Abstract

The Indian pharmaceutical sector is large and has the potential of a global leader for low-priced high-quality drugs. The new patent regulations had a strong impact on the drug industry in India. There is a serious decline in the number of pharma patents recently after compulsory licensing for drugs was implemented in India. While regulations are meant for reducing the prices of essential drugs, there are investment-related issues when a patent is subjected to voluntary licensing. The present study focuses on three phases in pharmaceutical patenting identified by analysing the major patent databases and the potential shift in pharma patenting sector from acute to lifestyle disease-based drugs. The recent trend identified in the pharma patenting sector in India is quite unusual and unreported so far.

Keywords

Compulsory Licensing, Generic Drug Market, Indian Pharma Market, Lifestyle Diseases, Pharma Patenting Trends.

Full Text

   

Vikram Singh ¹, Kajal Chakraborty ²

Affiliations
1 Intellectual Property and Technology Management Unit, Indian Council of Agricultural Research (ICAR), New Delhi 110 012, IN
2 Institute Technology Management Unit (ITMU), Central Marine Fisheries Research Institute, Kochi 682 018, IN

Abstract

Patents are the protected form of innovations and the currency of a knowledge-based economy. This article is an outcome of the analysis of working of patents data, which were published on the Indian Patent Office (IPO) website during 2012 and 2013, and continuously updated thereafter. For an overview of working of patents in India, an aggregate of 64 companies and/or organizations were selected for this study. The results of the analysis revealed that Qualcomm topped the list with 1113 granted patents at IPO, followed by Council of Scientific and Industrial Research (1085), Hindustan Unilever (773), Samsung Electronics (705), and Philips (352). The objective of this study was to determine the workability of patents in India, and the results indicated that all the seven patents granted to Indofil (an Indian company, which manufacturers agricultural, specialty and performance chemicals) were in working conditions, which apparently signified that the firm had effectively transferred the innovations for production and for the end-user. IPO was preferred as an important patent filling offices (PFO) by different national and international companies for filling their innovations. The results of this study provide an opportunity for the inventors, market players, researchers and consumers to know about the innovations which are lying in the PFOs of the different countries and lapsed after completing their life, i.e. 20 years.

Keywords

Companies and Organizations, Development and Commercialization, Innovations, Technology Transfer, Working of Patents.

Full Text